002826 易明医药
已收盘 01-07 15:00:00
资讯
新帖
简况
易明医药(002826.SZ)补缴税款1217.1万元
智通财经 · 2024-12-27
易明医药(002826.SZ)补缴税款1217.1万元
易明医药最新公告：公司及子公司需补缴税款1217.10万元
证券之星 · 2024-12-27
易明医药最新公告：公司及子公司需补缴税款1217.10万元
易明医药（002826）12月25日主力资金净卖出1067.53万元
证券之星 · 2024-12-25
易明医药（002826）12月25日主力资金净卖出1067.53万元
易明医药(002826.SZ)：第三方合作产品瓜蒌皮注射液(新通®)终止合作
智通财经 · 2024-12-24
易明医药(002826.SZ)：第三方合作产品瓜蒌皮注射液(新通®)终止合作
【易明医药：与上海医药合作经营的第三方产品瓜蒌皮注射液终止合作】易明医药公告，公司与上海医药集团股份有限公司子公司合作经营的产品瓜蒌皮注射液（新通®），协议于2024年12月后不再续约。该产品2024年产生的营业收入预计8500万元，占公司最近一期经审计的营业收入10%以上。合作终止是基于市场环境变化及公司战略规划调整，集中资源发展自产产品，保持自产产品业绩增长。此决策不会对公司财务及经营状况产生重大影响，不存在损害公司及中小股东权益的情形。
金融界 · 2024-12-24
【易明医药：与上海医药合作经营的第三方产品瓜蒌皮注射液终止合作】易明医药公告，公司与上海医药集团股份有限公司子公司合作经营的产品瓜蒌皮注射液（新通®），协议于2024年12月后不再续约。该产品2024年产生的营业收入预计8500万元，占公司最近一期经审计的营业收入10%以上。合作终止是基于市场环境变化及公司战略规划调整，集中资源发展自产产品，保持自产产品业绩增长。此决策不会对公司财务及经营状况产生重大影响，不存在损害公司及中小股东权益的情形。
易明医药(002826.SZ)拟推486万股限制性股票激励计划
智通财经 · 2024-12-16
易明医药(002826.SZ)拟推486万股限制性股票激励计划
易明医药（002826）12月12日主力资金净买入919.43万元
证券之星 · 2024-12-12
易明医药（002826）12月12日主力资金净买入919.43万元
异动快报：易明医药（002826）12月11日9点41分触及涨停板
证券之星 · 2024-12-11
异动快报：易明医药（002826）12月11日9点41分触及涨停板
12月9日易明医药涨停分析：西藏，医药，中药概念热股
证券之星 · 2024-12-09
12月9日易明医药涨停分析：西藏，医药，中药概念热股
异动快报：易明医药（002826）12月9日9点45分触及涨停板
证券之星 · 2024-12-09
异动快报：易明医药（002826）12月9日9点45分触及涨停板
易明医药(002826)11月20日股东户数1.69万户，较上期减少4%
证券之星 · 2024-11-29
易明医药(002826)11月20日股东户数1.69万户，较上期减少4%
易明医药（002826）11月27日主力资金净卖出855.91万元
证券之星 · 2024-11-27
易明医药（002826）11月27日主力资金净卖出855.91万元
易明医药(002826.SZ)聘任崔京生、杨莲为副总经理
智通财经 · 2024-11-27
易明医药(002826.SZ)聘任崔京生、杨莲为副总经理
易明医药（002826）11月26日主力资金净买入5373.02万元
证券之星 · 2024-11-26
易明医药（002826）11月26日主力资金净买入5373.02万元
异动快报：易明医药（002826）11月26日13点0分触及涨停板
证券之星 · 2024-11-26
异动快报：易明医药（002826）11月26日13点0分触及涨停板
11月8日易明医药涨停分析：中药，医药，西藏概念热股
证券之星 · 2024-11-08
11月8日易明医药涨停分析：中药，医药，西藏概念热股
异动快报：易明医药（002826）11月8日9点55分触及涨停板
证券之星 · 2024-11-08
异动快报：易明医药（002826）11月8日9点55分触及涨停板
易明医药公布三季报 前三季净利增加75.06%
新浪财经-鹰眼工作室 · 2024-10-30
易明医药公布三季报 前三季净利增加75.06%
易明医药(002826.SZ)发布前三季度业绩，净利润4181.94万元，同比增长75.06%
智通财经 · 2024-10-29
易明医药(002826.SZ)发布前三季度业绩，净利润4181.94万元，同比增长75.06%
易明医药（002826）10月28日主力资金净买入818.13万元
证券之星 · 2024-10-28
易明医药（002826）10月28日主力资金净买入818.13万元
加载更多
公司概况
公司名称：
西藏易明西雅医药科技股份有限公司
所属行业：
医药制造业
上市日期：
2016-12-09
主营业务：
西藏易明西雅医药科技股份有限公司主要从事化学药（原料药和制剂）以及中成药的研发、生产和销售。公司主要产品为米格列醇片、醋氯芬酸肠溶片、红金消结片、蒙脱石散、多潘立酮片、阿奇霉素胶囊、氯雷他定片、第三方合作药品。公司重点经营的产品均在品质、资质上具有突出特点，全部列入《国家基本医疗保险、工伤保险和生育保险药品目录》（2022年版），部分产品列入国家基本药物目录，具备全国独家、首家仿制等优势，在细分市场上均具有较强的竞争力和较好的成长空间。
发行价格：
6.06
{"stockData":{"symbol":"002826","market":"SZ","secType":"STK","nameCN":"易明医药","latestPrice":10.12,"timestamp":1736233428000,"preClose":9.9,"halted":0,"volume":4463200,"delay":0,"changeRate":0.0222,"floatShares":176000000,"shares":191000000,"eps":0.1748,"marketStatus":"已收盘","change":0.22,"latestTime":"01-07 15:00:00","open":9.95,"high":10.15,"low":9.8,"amount":44588400,"amplitude":0.0354,"askPrice":10.14,"askSize":11,"bidPrice":10.12,"bidSize":322,"shortable":0,"etf":0,"ttmEps":0.1748,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1736299800000},"marketStatusCode":5,"adr":0,"adjPreClose":9.9,"symbolType":"stock","openAndCloseTimeList":[[1736213400000,1736220600000],[1736226000000,1736233200000]],"highLimit":10.89,"lowLimit":8.91,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":190677750,"isCdr":false,"pbRate":2.58,"roa":"--","peRate":57.894737,"roe":"5.68%","epsLYR":0.08,"committee":-0.265993,"marketValue":1930000000,"turnoverRate":0.0254,"status":0,"floatMarketCap":1782000000},"requestUrl":"/m/hq/s/002826","defaultTab":"news","newsList":[{"id":"2494580452","title":"易明医药(002826.SZ)补缴税款1217.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494580452","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494580452?lang=zh_cn&edition=full","pubTime":"2024-12-27 20:19","pubTimestamp":1735301964,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药(002826.SZ)发布公告，经自查，公司及子公司需补缴企业所得税465.13万元，增值税及附加648.47万元，滞纳金103.50万元，合计1217.10万元。目前，公司及子公司已将上述税款及滞纳金缴纳完毕，主管税务部门未对该事项给予处罚。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1230342.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","002826","BK0033","BK0056"],"gpt_icon":0},{"id":"2494801639","title":"易明医药最新公告：公司及子公司需补缴税款1217.10万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494801639","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494801639?lang=zh_cn&edition=full","pubTime":"2024-12-27 20:00","pubTimestamp":1735300857,"startTime":"0","endTime":"0","summary":"易明医药公告，公司及子公司近期对涉税业务开展了自查，经自查，公司及子公司需补缴企业所得税465.13万元，增值税及附加648.47万元，滞纳金103.50万元，合计1217.10万元。目前，公司及子公司已将上述税款及滞纳金缴纳完毕，主管税务部门未对该事项给予处罚。补缴税款及滞纳金将计入2024年当期损益，预计将影响公司2024年度归属于上市公司股东的净利润1217.10万元。本事项不会对公司的正常经营产生重大影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122700039815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0033","BK0056"],"gpt_icon":0},{"id":"2494832016","title":"易明医药（002826）12月25日主力资金净卖出1067.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2494832016","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494832016?lang=zh_cn&edition=full","pubTime":"2024-12-25 15:29","pubTimestamp":1735111790,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月25日收盘，易明医药报收于10.42元，下跌7.62%，换手率4.83%，成交量8.5万手，成交额8920.9万元。易明医药主营业务：自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122500021129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK0056","BK0033"],"gpt_icon":0},{"id":"2493771697","title":"易明医药(002826.SZ)：第三方合作产品瓜蒌皮注射液(新通®)终止合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2493771697","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493771697?lang=zh_cn&edition=full","pubTime":"2024-12-24 15:51","pubTimestamp":1735026682,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药 发布公告，公司经营的第三方合作产品瓜蒌皮注射液(新通)系公司与上海医药子公司合作经营的品种。目前，公司与上海医药经过充分协商，决定终止合作，协议于2024年12月后不再续约。经过财务部门的初步测算，该产品2024年产生的营业收入预计8500万元，占公司最近一期经审计的营业收入10%以上。公司会进一步聚焦自产产品，推动公司持续健康发展，提升公司综合竞争力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1228930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0056","002826","BK0033","BK0239"],"gpt_icon":0},{"id":"2493977143","title":"【易明医药：与上海医药合作经营的第三方产品瓜蒌皮注射液终止合作】易明医药公告，公司与上海医药集团股份有限公司子公司合作经营的产品瓜蒌皮注射液（新通®），协议于2024年12月后不再续约。该产品2024年产生的营业收入预计8500万元，占公司最近一期经审计的营业收入10%以上。合作终止是基于市场环境变化及公司战略规划调整，集中资源发展自产产品，保持自产产品业绩增长。此决策不会对公司财务及经营状况产生重大影响，不存在损害公司及中小股东权益的情形。","url":"https://stock-news.laohu8.com/highlight/detail?id=2493977143","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493977143?lang=zh_cn&edition=full","pubTime":"2024-12-24 15:49","pubTimestamp":1735026574,"startTime":"0","endTime":"0","summary":"易明医药公告，公司与上海医药集团股份有限公司子公司合作经营的产品瓜蒌皮注射液（新通®），协议于2024年12月后不再续约。该产品2024年产生的营业收入预计8500万元，占公司最近一期经审计的营业收入10%以上。合作终止是基于市场环境变化及公司战略规划调整，集中资源发展自产产品，保持自产产品业绩增长。此决策不会对公司财务及经营状况产生重大影响，不存在损害公司及中小股东权益的情形。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/24154946739359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02607","002826","601607"],"gpt_icon":0},{"id":"2491669303","title":"易明医药(002826.SZ)拟推486万股限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2491669303","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491669303?lang=zh_cn&edition=full","pubTime":"2024-12-16 19:11","pubTimestamp":1734347504,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药(002826.SZ)披露2024年限制性股票激励计划(草案)，拟授予激励对象的限制性股票数量为486万股，约占激励计划草案公布日公司股本总额的2.55%。其中，首次授予限制性股票450万股，首次授予激励对象共计35人，授予价格为6.45元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225535.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK0033","BK0056","002826"],"gpt_icon":0},{"id":"2490038873","title":"易明医药（002826）12月12日主力资金净买入919.43万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490038873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490038873?lang=zh_cn&edition=full","pubTime":"2024-12-12 15:29","pubTimestamp":1733988586,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月12日收盘，易明医药报收于12.96元，下跌2.56%，换手率10.82%，成交量19.06万手，成交额2.49亿元。易明医药主营业务：自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121200019487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0033","BK0056"],"gpt_icon":0},{"id":"2490070489","title":"异动快报：易明医药（002826）12月11日9点41分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2490070489","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490070489?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:45","pubTimestamp":1733881545,"startTime":"0","endTime":"0","summary":"证券之星12月11日盘中消息，9点41分易明医药（002826）触及涨停板。目前价格13.62，上涨10.02%。其所属行业化学制药目前上涨。领涨股为宣泰医药。该股为西藏，中药，医药概念热股，当日西藏概念上涨0.51%，中药概念上涨0.46%，医药概念上涨0.45%。12月10日的资金流向数据方面，主力资金净流出1515.35万元，占总成交额5.17%，游资资金净流入64.39万元，占总成交额0.22%，散户资金净流入1450.95万元，占总成交额4.95%。近5日资金流向一览见下表：易明医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121100010241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"gpt_icon":0},{"id":"2490711660","title":"12月9日易明医药涨停分析：西藏，医药，中药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490711660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490711660?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:13","pubTimestamp":1733728406,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药12月9日涨停收盘，收盘价12.69元。该股于9点30分涨停，14次打开涨停，截止收盘封单资金为1164.43万元，占其流通市值0.52%。12月9日的资金流向数据方面，主力资金净流入3685.7万元，占总成交额13.94%，游资资金净流出1349.28万元，占总成交额5.1%，散户资金净流出2336.41万元，占总成交额8.83%。近5日资金流向一览见下表：该股为西藏，医药，中药概念热股，当日西藏概念上涨1.61%，医药概念上涨0.55%，中药概念上涨0.25%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900013436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","159938","09939","BK0239","BK1574","BK0056","BK1161","002826","BK1515"],"gpt_icon":0},{"id":"2490760581","title":"异动快报：易明医药（002826）12月9日9点45分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2490760581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490760581?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:50","pubTimestamp":1733709038,"startTime":"0","endTime":"0","summary":"证券之星12月9日盘中消息，9点45分易明医药（002826）触及涨停板。目前价格12.69，上涨9.97%。其所属行业化学制药目前上涨。领涨股为河化股份。该股为西藏，医药，中药概念热股，当日西藏概念上涨1.33%，医药概念上涨1.12%，中药概念上涨0.86%。12月6日的资金流向数据方面，主力资金净流出1635.55万元，占总成交额14.89%，游资资金净流入593.92万元，占总成交额5.41%，散户资金净流入1041.63万元，占总成交额9.48%。近5日资金流向一览见下表：易明医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900004333.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"gpt_icon":0},{"id":"2487009538","title":"易明医药(002826)11月20日股东户数1.69万户，较上期减少4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487009538","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487009538?lang=zh_cn&edition=full","pubTime":"2024-11-29 17:02","pubTimestamp":1732870953,"startTime":"0","endTime":"0","summary":"证券之星消息，近日易明医药披露，截至2024年11月20日公司股东户数为1.69万户，较10月31日减少703.0户，减幅为4.0%。在化学制药行业个股中，易明医药股东户数低于行业平均水平，截至11月20日，化学制药行业平均股东户数为3.11万户。从股价来看，2024年10月31日至2024年11月20日，易明医药区间涨幅为12.56%，在此期间股东户数减少703.0户，减幅为4.0%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112900025346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"gpt_icon":0},{"id":"2486155018","title":"易明医药（002826）11月27日主力资金净卖出855.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486155018","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486155018?lang=zh_cn&edition=full","pubTime":"2024-11-27 15:27","pubTimestamp":1732692457,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月27日收盘，易明医药报收于11.7元，下跌3.94%，换手率7.94%，成交量13.97万手，成交额1.63亿元。易明医药主营业务：自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700019977.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0056","BK0033","002826"],"gpt_icon":0},{"id":"2486988098","title":"易明医药(002826.SZ)聘任崔京生、杨莲为副总经理","url":"https://stock-news.laohu8.com/highlight/detail?id=2486988098","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486988098?lang=zh_cn&edition=full","pubTime":"2024-11-27 11:49","pubTimestamp":1732679359,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药(002826.SZ)发布公告，公司近年来一直在加强人才梯队建设，注重内部人才培养，增强管理层力量，以满足公司未来经营发展的需要。根据《公司法》《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第1号——主板上市公司规范运作》等法律法规及《公司章程》等有关规定。经第三届董事会提名委员会审核，公司董事会同意聘任崔京生先生、杨莲女士为公司副总经理，任期自本次董事会审议通过之日起至第三届董事会任期截止之日止。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0056","BK0033","BK0239","002826"],"gpt_icon":0},{"id":"2486041474","title":"易明医药（002826）11月26日主力资金净买入5373.02万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486041474","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486041474?lang=zh_cn&edition=full","pubTime":"2024-11-26 15:19","pubTimestamp":1732605588,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月26日收盘，易明医药报收于12.18元，上涨6.19%，换手率12.9%，成交量22.72万手，成交额2.8亿元。易明医药主营业务：自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600020368.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0056","002826","BK0239","BK0033"],"gpt_icon":0},{"id":"2486901271","title":"异动快报：易明医药（002826）11月26日13点0分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2486901271","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486901271?lang=zh_cn&edition=full","pubTime":"2024-11-26 13:00","pubTimestamp":1732597251,"startTime":"0","endTime":"0","summary":"证券之星11月26日盘中消息，13点0分易明医药（002826）触及涨停板。目前价格12.62，上涨10.03%。其所属行业化学制药目前上涨。领涨股为一品红。该股为中药，医药，西藏概念热股，当日中药概念上涨1.89%，医药概念上涨1.41%，西藏概念上涨0.63%。11月26日的资金流向数据方面，主力资金净流入3262.15万元，占总成交额18.95%，游资资金净流出1290.37万元，占总成交额7.5%，散户资金净流出1971.78万元，占总成交额11.46%。近5日资金流向一览见下表：易明医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600019050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002826","BK0033","BK0056"],"gpt_icon":0},{"id":"2481148154","title":"11月8日易明医药涨停分析：中药，医药，西藏概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481148154","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481148154?lang=zh_cn&edition=full","pubTime":"2024-11-08 15:22","pubTimestamp":1731050526,"startTime":"0","endTime":"0","summary":"证券之星消息，易明医药11月8日涨停收盘，收盘价11.35元。该股于9点55分涨停，未打开涨停，截止收盘封单资金为6167.1万元，占其流通市值3.09%。11月8日的资金流向数据方面，主力资金净流入3718.25万元，占总成交额27.57%，游资资金净流出1579.58万元，占总成交额11.71%，散户资金净流出2138.67万元，占总成交额15.86%。近5日资金流向一览见下表：该股为中药，医药，西藏概念热股。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800019765.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002826","BK0239","BK1574","BK0056","BK1161","159938","BK1515","BK0033","09939"],"gpt_icon":0},{"id":"2481164158","title":"异动快报：易明医药（002826）11月8日9点55分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2481164158","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481164158?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:01","pubTimestamp":1731031270,"startTime":"0","endTime":"0","summary":"证券之星11月8日盘中消息，9点55分易明医药（002826）触及涨停板。目前价格11.35，上涨9.98%。其所属行业化学制药目前上涨。领涨股为海南海药。该股为中药，医药，西藏概念热股，当日中药概念上涨0.82%，医药概念上涨0.7%，西藏概念上涨0.11%。11月7日的资金流向数据方面，主力资金净流入1021.51万元，占总成交额10.18%，游资资金净流出527.01万元，占总成交额5.25%，散户资金净流出494.5万元，占总成交额4.93%。近5日资金流向一览见下表：易明医药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800010467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0033","BK0056","002826"],"gpt_icon":0},{"id":"2479231203","title":"易明医药公布三季报 前三季净利增加75.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479231203","media":"新浪财经-鹰眼工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479231203?lang=zh_cn&edition=full","pubTime":"2024-10-30 01:10","pubTimestamp":1730221800,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 10月30日消息，易明医药发布三季度报告。 公告显示，公司前三季度营业收入512,843,177.87元，同比减少4.73%，归属上市公司股东的净利润41,819,396.00元，同比增加75.06%。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：小浪快报","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-10-30/doc-incufzcn1642532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK0056","BK0033","002826"],"gpt_icon":0},{"id":"2479402309","title":"易明医药(002826.SZ)发布前三季度业绩，净利润4181.94万元，同比增长75.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479402309","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479402309?lang=zh_cn&edition=full","pubTime":"2024-10-29 20:51","pubTimestamp":1730206319,"startTime":"0","endTime":"0","summary":"智通财经APP讯，易明医药(002826.SZ)发布2024年三季度报告，前三季度，公司实现营业收入5.13亿元，同比下降4.73%。归属于上市公司股东的净利润4181.94万元，同比增长75.06%。归属于上市公司股东的扣除非经常性损益的净利润1633.85万元，同比增长49.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1202860.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["002826"],"gpt_icon":0},{"id":"2478124103","title":"易明医药（002826）10月28日主力资金净买入818.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478124103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478124103?lang=zh_cn&edition=full","pubTime":"2024-10-28 15:21","pubTimestamp":1730100100,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月28日收盘，易明医药报收于10.28元，上涨7.64%，换手率7.55%，成交量13.29万手，成交额1.34亿元。易明医药主营业务：自主生产药品业务,第三方合作药品业务,原料药业务,药品原材料销售业务,药品推广服务业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800013577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0033","BK0239","BK0056","002826"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-12-09","address":"西藏自治区拉萨市堆龙德庆区经济技术开发区林琼岗路6号","stockEarnings":[{"period":"1week","weight":-0.0232},{"period":"1month","weight":-0.1231},{"period":"3month","weight":0.1606},{"period":"6month","weight":0.2556},{"period":"1year","weight":-0.1306},{"period":"ytd","weight":-0.0232}],"companyName":"西藏易明西雅医药科技股份有限公司","boardCode":"AI0027","perCapita":"11263股","boardName":"医药制造业","registeredCapital":"19067万元","compareEarnings":[{"period":"1week","weight":-0.0364},{"period":"1month","weight":-0.0512},{"period":"3month","weight":-0.009},{"period":"6month","weight":0.0873},{"period":"1year","weight":0.1185},{"period":"ytd","weight":-0.0364}],"survey":" 西藏易明西雅医药科技股份有限公司主要从事化学药（原料药和制剂）以及中成药的研发、生产和销售。公司主要产品为米格列醇片、醋氯芬酸肠溶片、红金消结片、蒙脱石散、多潘立酮片、阿奇霉素胶囊、氯雷他定片、第三方合作药品。公司重点经营的产品均在品质、资质上具有突出特点，全部列入《国家基本医疗保险、工伤保险和生育保险药品目录》（2022年版），部分产品列入国家基本药物目录，具备全国独家、首家仿制等优势，在细分市场上均具有较强的竞争力和较好的成长空间。","serverTime":1736289151151,"listedPrice":6.06,"stockholders":"15631人(较上一季度减少4.59%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"易明医药,002826,易明医药股票,易明医药股票老虎,易明医药股票老虎国际,易明医药行情,易明医药股票行情,易明医药股价,易明医药股市,易明医药股票价格,易明医药股票交易,易明医药股票购买,易明医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"易明医药(002826)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供易明医药(002826)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}